Clinical Trial Update: Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of letrozole and lapatinib followed by everolimus in women with advanced breast cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Everolimus (everolimus)
• Lapatinib (Lapatinib)
• Letrozole (letrozole)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Breast Neoplasms, Endocrine Breast Diseases | Phase 2 | Status: TERMINATED | Results posted: 2018-03-06